Invirsa, Inc.
Clinical trials sponsored by Invirsa, Inc., explained in plain language.
-
Could eye drops replace needles for diabetic eye swelling?
Disease control CompletedThis small Phase 2 study tested INV-102 eye drops in 19 people with diabetic macular edema, a swelling in the back of the eye caused by diabetes. Participants used the drops daily for 8 to 12 weeks. The goal was to see if the drops could improve retinal health and reduce swelling…
Phase: PHASE2 • Sponsor: Invirsa, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New eyedrops aim to soothe dry, irritated eyes
Symptom relief CompletedThis early-stage trial tested an experimental eyedrop called INV-102 in 84 adults with moderate dry eye disease. The study had two parts: first, checking safety at different doses, and second, seeing if the drops improve eye dryness symptoms after two weeks. Participants used the…
Phase: PHASE1, PHASE2 • Sponsor: Invirsa, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC